Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Trinity Health and Wellness Center CRS (31443)
mi
from
Dallas, TX
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Trinity Health and Wellness Center CRS (31443)
mi
from
Dallas, TX
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS (31473)
mi
from
Houston, TX
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS (31473)
mi
from
Houston, TX
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Click here to add this to my saved trials
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated:  12/31/1969
Washington University CRS (2101)
mi
from
Saint Louis, MO
High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART
A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Status: Enrolling
Updated: 12/31/1969
Washington University CRS (2101)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Bronx-Lebanon Hospital Center NICHD CRS
mi
from
Bronx, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Bronx-Lebanon Hospital Center NICHD CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Chapel Hill CRS
mi
from
Chapel Hill, NC
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Denver Public Health CRS
mi
from
Denver, CO
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Denver Public Health CRS
mi
from
Denver, CO
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA CRS
mi
from
Torrance, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Nyu Ny Nichd Crs
mi
from
New York, NY
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Nyu Ny Nichd Crs
mi
from
New York, NY
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
The University of Miami AIDS Clinical Research Unit (ACRU) CRS
mi
from
Miami, FL
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Southern California CRS
mi
from
Los Angeles, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Boston Medical Center CRS
mi
from
Boston, MA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Boston Medical Center CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Duke University Medical Center CRS
mi
from
Durham, NC
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Duke University Medical Center CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
Gaborone CRS
mi
from
Gaborone,
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
Gaborone CRS
mi
from
Gaborone,
Click here to add this to my saved trials
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated:  12/31/1969
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
mi
from
La Jolla, CA
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Status: Enrolling
Updated: 12/31/1969
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
mi
from
La Jolla, CA
Click here to add this to my saved trials
Eplerenone in HIV Associated Abdominal Fat Accumulation
Randomized Placebo-controlled Trial to Investigate the Effects of Eplerenone in Patients With HIV-associated Abdominal Fat Accumulation
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Eplerenone in HIV Associated Abdominal Fat Accumulation
Randomized Placebo-controlled Trial to Investigate the Effects of Eplerenone in Patients With HIV-associated Abdominal Fat Accumulation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated:  12/31/1969
VAMC Atlanta
mi
from
Atlanta, GA
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated: 12/31/1969
VAMC Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated:  12/31/1969
New York VAMC - New York Harbor Healthcare System
mi
from
New York, NY
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated: 12/31/1969
New York VAMC - New York Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated:  12/31/1969
VAMC Houston
mi
from
Houston, TX
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated: 12/31/1969
VAMC Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated:  12/31/1969
Washington DC VAMC
mi
from
Washington,
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Status: Enrolling
Updated: 12/31/1969
Washington DC VAMC
mi
from
Washington,
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
City of Hope National Medical Center
mi
from
Duarte, CA
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
University of CA, SF
mi
from
San Francisco, CA
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
University of CA, SF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Blood and Marrow Transplant Program at Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins
mi
from
Baltimore, MD
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
University of Texas, MD Anderson CRC
mi
from
Houston, TX
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
University of Texas, MD Anderson CRC
mi
from
Houston, TX
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Texas Transplant Institute
mi
from
San Antonio, TX
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (BMT CTN #0903)
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
The HJ MILE HIV Prevention Intervention for Post-incarcerated Men
The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men
Status: Enrolling
Updated:  12/31/1969
Center for Health Justice
mi
from
Los Angeles, CA
The HJ MILE HIV Prevention Intervention for Post-incarcerated Men
The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men
Status: Enrolling
Updated: 12/31/1969
Center for Health Justice
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
A Phase I Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Replication-defective HIV-1 Vaccine (HIVAX™) in HIV-1 Infected Subjects Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
University of Miami School of Medicine, AIDS Clinical Research unit
mi
from
Miami, FL
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
A Phase I Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of a Replication-defective HIV-1 Vaccine (HIVAX™) in HIV-1 Infected Subjects Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
University of Miami School of Medicine, AIDS Clinical Research unit
mi
from
Miami, FL
Click here to add this to my saved trials
Safer Sex Program for Young African-American Men
A Brief, Clinic-Based, Safer Sex Program for Young African-American Men
Status: Enrolling
Updated:  12/31/1969
Mississippi State Department of Health STD Clinic
mi
from
Jackson, MS
Safer Sex Program for Young African-American Men
A Brief, Clinic-Based, Safer Sex Program for Young African-American Men
Status: Enrolling
Updated: 12/31/1969
Mississippi State Department of Health STD Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Management of Hepatitis C in HIV Infected IDUs
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Management of Hepatitis C in HIV Infected IDUs
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
A Pilot Study of Rifaximin as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Individuals With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS (5801)
mi
from
Birmingham, AL
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
A Pilot Study of Rifaximin as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Individuals With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS (5801)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
A Pilot Study of Rifaximin as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Individuals With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
A Pilot Study of Rifaximin as a Modulator of Gut Microbial Translocation and Systemic Immune Activation in HIV-Infected Individuals With Incomplete CD4+ T-cell Recovery on Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Click here to add this to my saved trials